Summary: Cagrilintide and retatrutide are investigational injectable medicines being studied for obesity and type 2 diabetes in men, targeting multiple hormonal pathways to reduce appetite, improve blood glucose control, and increase energy expenditure, but neither is currently licensed in the UK
Symptoms may include: Shortness of breath Red, flushed skin Headaches Rapid weight gain, polycythemia (increased red cell mass), hypokalemia, CHF, pulmonary edema, and vascular thrombosis are mostly observed in therapeutic contexts where vitamin B12 is administered aggressively or over extended periods
Injections deliver B12 directly into the bloodstream, bypassing digestion for faster absorption and noticeable resultsoften within hours or days
The Bottom Line Sermorelin may indirectly increase testosterone production by directly increases testosterone production by stimulating your body to create more human growth hormone (hGH)